Literature DB >> 20041411

Serum cytokeratin-18 fragment level: a noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis.

Xiaohua Li, Ying Zhang, Kaichun Wu, Daiming Fan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20041411     DOI： 10.1002/hep.23433

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

2.  Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.

Authors:  Vanessa Jeannette Lavallard; Stéphanie Bonnafous; Stéphanie Patouraux; Marie-Christine Saint-Paul; Déborah Rousseau; Rodolphe Anty; Yannick Le Marchand-Brustel; Albert Tran; Philippe Gual
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

3.  Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease.

Authors:  Young Seok Kim; Eun Sun Jung; Wonhee Hur; Si Hyun Bae; Jong Young Choi; Myeong Jun Song; Chang Wook Kim; Se Hyun Jo; Chang Don Lee; Young Sok Lee; Sang Wook Choi; Jin Mo Yang; Jeong Won Jang; Sang Gyune Kim; Seung Won Jung; Hee Kyung Kim; Hee Bok Chae; Seung Kew Yoon
Journal:  Clin Mol Hepatol       Date:  2013-06-27

4.  Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.

Authors:  Tomohiro Sekiguchi; Takeji Umemura; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.